Diagnosis: Mycosis fungoides, patch stage
This case presents a 62-year-old male with persistent hypopigmented patches on sun-protected areas, notably the trunk and upper arms, that have evolved over the past year. Clinical examination reveals asymmetrical distribution and subtle scaling, raising suspicion for a cutaneous lymphoproliferative disorder.
A 62-year-old male presented with persistent hypopigmented patches on sun-protected areas, specifically the trunk and upper arms, for the past 12 months. The patient reported no associated symptoms such as itching or pain. On examination, asymmetrical patches were noted with slight scaling and well-defined borders.Age: 62-year-old maleDuration: 12 monthsLesions: Asymmetrical hypopigmented patchesLocation: Sun-protected areas (trunk, upper arms)Scaling: Subtle, with well-defined borders
The onset of the lesions was insidious, with no identifiable triggers. The patient has a history of mild eczema in childhood but has not received any specific treatments for the current condition. He has no significant family history of skin disorders and is a non-smoker. There are no recent changes in medications or environmental exposures.Onset: Insidious, over 12 monthsTriggers: None identifiedPast medical history: Mild childhood eczemaFamily history: No significant skin disordersSocial history: Non-smoker, no recent medication changes
Acute / First-Line ManagementTopical corticosteroids (e.g., betamethasone dipropionate 0.05% ointment applied twice daily) for symptomatic relief and inflammation control.Phototherapy with narrowband UVB (twice weekly sessions) for patients with more extensive disease.Workup and Diagnostic ConfirmationSkin biopsy of an affected area to assess for atypical lymphoid infiltrate, typically showing a band-like infiltrate at the dermal-epidermal junction.Immunohistochemical staining for CD4 and CD8 to characterize the T-cell population.Consideration of T-cell receptor (TCR) gene rearrangement studies if the diagnosis remains uncertain.Long-Term ManagementRegular follow-up to monitor for progression of disease, with reassessment of treatment efficacy.Consideration of systemic therapies (e.g., interferon-alpha or low-dose methotrexate) if lesions progress or fail to respond to topical therapies.Patient education regarding skin care and sun protection to minimize potential exacerbation of lesions.
Pityriasis lichenoides chronica: Characterized by small, red-brown papules that can coalesce; typically presents with more raised lesions than patches seen in this case.Psoriasis: Presents with well-defined, erythematous plaques with silvery scales, usually affecting extensor surfaces; less common in sun-protected areas.Vitiligo: Causes depigmentation but is usually not scaly and has a more symmetric distribution; often associated with autoimmune disorders.Drug-induced skin changes: Certain medications can cause hypopigmented patches; history of recent medication changes is crucial for this diagnosis.Granuloma annulare: Presents as annular plaques, typically on the dorsal surfaces of hands and feet; lesions are often skin-colored or slightly erythematous.Secondary syphilis: May present with hypopigmented lesions; however, other systemic signs are usually present, such as mucous membrane involvement.Dermatitis: Contact or atopic dermatitis can cause varied presentations but typically includes pruritus and inflammation, which are absent in this case.Secondary cutaneous T-cell lymphoma: Must be considered in cases with atypical lymphoid infiltrates; however, this would typically present with more aggressive features.
High-Yield PearlsAsymmetry: Asymmetrical distribution of skin lesions is a key feature in distinguishing mycosis fungoides from other benign dermatoses.Biopsy: Skin biopsy remains the gold standard for diagnosis, particularly looking for atypical lymphoid infiltrates.Topical treatments: First-line management often includes topical corticosteroids to reduce inflammation and control symptoms.Phototherapy: Narrowband UVB is an effective first-line treatment for patch-stage mycosis fungoides.Long-term monitoring: Regular follow-ups are essential to assess for disease progression and treatment response.Recognition of atypical skin lesions in sun-protected areas is crucial for early diagnosis of cutaneous T-cell lymphomas.
Tags: mycosis fungoides, CTCL, patch stage